GUJTHEM — Gujarat Themis Biosyn Cashflow Statement
0.000.00%
- IN₹37.76bn
- IN₹37.93bn
- IN₹1.51bn
Annual cashflow statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 409 | 590 | 775 | 793 | 655 |
Depreciation | |||||
Non-Cash Items | -19.7 | -20.7 | -50.1 | -36 | -5.05 |
Other Non-Cash Items | |||||
Changes in Working Capital | -301 | -189 | -355 | -156 | 203 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 105 | 403 | 395 | 642 | 910 |
Capital Expenditures | -30.6 | -139 | -237 | -746 | -1,162 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 8.06 | -159 | 32.9 | 194 | 43.3 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -22.5 | -298 | -204 | -552 | -1,118 |
Financing Cash Flow Items | -4.5 | -2.05 | -1.11 | -0.894 | -4.28 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -51.6 | -140 | -133 | -85.9 | 260 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 31.1 | -35.1 | 57.9 | 4.14 | 52.2 |